Epigenomic subtypes of late-onset Alzheimer’s disease reveal distinct microglial signatures - Top-Institutions - MDSpire

Epigenomic subtypes of late-onset Alzheimer’s disease reveal distinct microglial signatures

  • By

  • Valentin T. Laroche

  • Rachel Cavill

  • Morteza Kouhsar

  • Joshua Müller

  • Rick A. Reijnders

  • Joshua Harvey

  • Adam R. Smith

  • Jennifer Imm

  • Jarno Koetsier

  • Luke Weymouth

  • Lachlan MacBean

  • Giulia Pegoraro

  • Lars Eijssen

  • Byron Creese

  • Gunter Kenis

  • Betty M. Tijms

  • Daniel van den Hove

  • Katie Lunnon

  • Ehsan Pishva

  • February 24, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Neurology
    • Neurodegenerative Diseases
    • Genomics
    • Epigenetics

  • #2

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Neurology
    • Neurogenetics
    • Epigenetics
    • Proteomics

  • #3

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Neurology
    • Neurodegeneration
    • Molecular Biology
    • Epigenomics

  • #4

    Washington University in St. Louis
    Washington University in St. Louis

    St. Louis, MO

    Key Differentiators

    • Neurology
    • Neurogenetics
    • Epigenetics
    • Bioinformatics

  • #5

    The Mayo Clinic
    The Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Neurology
    • Neurodegenerative Diseases
    • Proteomics
    • Epigenetics

Original Source(s)

Epigenomic subtypes of late-onset Alzheimer’s disease reveal distinct microglial signatures

  • by Valentin T. Laroche, Rachel Cavill, Morteza Kouhsar, Joshua Müller, Rick A. Reijnders, Joshua Harvey, Adam R. Smith, Jennifer Imm, Jarno Koetsier, Luke Weymouth, Lachlan MacBean, Giulia Pegoraro, Lars Eijssen, Byron Creese, Gunter Kenis, Betty M. Tijms, Daniel van den Hove, Katie Lunnon, Ehsan Pishva

  • February 24, 2026

Related Content

Acceptability of Technologies to Support Early Dementia Detection: Qualitative Study With the Boston University Alzheimer’s Disease Center Cohort

Neuroinflammation in Alzheimer’s disease: glial crosstalk, pathological modulation, and therapeutic implications

AI-driven insights into protein misfolding and innate immunity in neurodegenerative diseases